Establishment of the new diagnostic procedure of oral cancer whichtargeted midkine and development of the therapy
Project/Area Number |
22592240
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Kumamoto University |
Principal Investigator |
OTA Kazutoshi 熊本大学, 医学部附属病院, 講師 (20336209)
|
Co-Investigator(Kenkyū-buntansha) |
SHINOHARA Masanori 熊本大学, 生命科学研究部, 教授 (90117127)
ANDO Yukio 熊本大学, 生命科学研究部, 教授 (20253742)
植田 光晴 熊本大学, 大学院・生命科学研究部, 助教 (60452885)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 臨床腫瘍学 / ミッドカイン / 口腔癌 / 腫瘍マーカー / 薬剤耐性 / 網羅的解析法 |
Research Abstract |
We demonstrated that serum midkine concentrations were a usefulmarker of oral squamous cell carcinoma (OSCC), because midkine protein overexpressed inOSCC tissues and blood of OSCC patients. Furthermore, we showed that the increased S-MKconcentrations in OSCC patients were strongly associated with poor survival. We suggestedthat mechanism by which for midkine inhibited a cell cycle and promoted angiogenesis wasinvolved in anticancer drug resistance. The drug-resistant change by the midkineexpression suppression may be a novel treatment strategy of the cancer therapy.
|
Report
(4 results)
Research Products
(12 results)
-
[Journal Article] Therapeutic approaches targetingmidkine suppress tumor growth and lungmetastasis in osteosarcoma2012
Author(s)
Sueyoshi T, Jono H, Shinriki S, Ota K,Ota T, Tasaki M, Atsuyama E, YakushijiT, Ueda M, Obayashi K, Mizuta H, AndoY
-
Journal Title
CancerLett
Volume: 316(1)
Pages: 23-30
Related Report
Peer Reviewed
-
[Journal Article] Downregulation of midkineinduces cisplatin resistance in humanoral squamous cell carcinoma2012
Author(s)
Ota T, Jono H, Ota K, Shinriki S, UedaM, Sueyoshi T, Nakatani K, Hiraishi Y,Wada T, Fujita S, Obayashi K, ShinoharaM, Ando Y
-
Journal Title
OncolRep
Volume: 27(5)
Pages: 1674-1680
Related Report
Peer Reviewed
-
[Journal Article] Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma.2012
Author(s)
Takanao Sueyoshi, Hirofumi Jono, Satoru Shinriki, Kazutoshi Ota, Tomoko Ota, Masayoshi Tasaki, Eri Atsuyama, Toshitake Yakushiji, Mitsuharu Ueda, Konen Obayashi, Hiroshi Mizuta, Yukio Ando
-
Journal Title
Cancer Letter
Volume: Volume 316, Issue 1
Issue: 1
Pages: 23-30
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] Interleukin-6 signallingregulates vascular endothelial growthfactor-C synthesis andlymphangiogenesis in human oralsquamous cell carcinoma2011
Author(s)
Shinriki S, Jono H, Ueda M, Ota K, OtaT, Sueyoshi T, Oike Y, Ibusuki M,Hiraki A, Nakayama H, Shinohara M, AndoY
-
Journal Title
J Pathol
Volume: 225(1)
Pages: 142-50
Related Report
Peer Reviewed
-
[Journal Article]2010
Author(s)
Ota K, Fujimori H, Ueda M, Jono H,Shinriki S, Ota T, Sueyoshi T, Taura M,Taguma A, Kai H, Shinohara M, AndoY
-
Journal Title
Int J Oncol
Volume: 37(4)
Pages: 797-804
Related Report
Peer Reviewed
-
-
[Journal Article] Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.2010
Author(s)
Kazutoshi Ota, Hiromi Fujimori, Mitsuharu Ueda, Hirofumi Jono, Satoru Shinriki, Tomoko Ota, Tak anao Sueyoshi, Manabu Taura, Ayaka Taguma, Hirofumi Kai, Masanori Shinohara, Yukio Ando
-
Journal Title
International Journal of Oncology
Volume: 37
Pages: 797-804
Related Report
Peer Reviewed
-
-
-
-